Brazil approves widespread use of Pfizer COVID-19 vaccine


Brazil’s health regulatory agency said Tuesday it had approved the Pfizer-BioNTech COVID-19 vaccine for widespread use, as the country races to secure enough doses to contain one of the world’s worst outbreaks.

“It gives me great pleasure to announce that after a 17-day review, (regulators) have granted the first approval in the Americas for widespread use of a vaccine against COVID-19,” said Antonio Barra Torres, the director of federal health regulator Anvisa, underlining that the approval was definitive and not only for emergency use.

For more coronavirus news, visit our dedicated page.

However, the vaccine is not yet available in Brazil, which is so far using two others: Chinese-developed CoronaVac and one developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca.

Read more:

Bolsonaro says China fast-tracking supplies for COVID-19 vaccines made in Brazil

New Brazil protests demand President Bolsonaro’s removal over COVID-19 response

Two million COVID-19 vaccines from India set to arrive in Brazil

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.